Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Cabazitaxel
Irinotecan HCl Trihydrate 99.5%
Entecavir
Carboplatin
Oxaliplatin
Cisplatin
Etoposide USP31
Palonosetron Hydrochloride
Capecitabine
Methotrexate
Pemetrexed disodium hydrate
Pemetrexed disodium hepthydrate
  N-1 stage of Paclitaxel and Docetaxel
7-Troc-Paclitaxel
7,10-di-Troc-Docetaxel
more...
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
more...
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
Ethyl (2R,3S)-3-Phenylisoserine Ester
more...
 
Your location:Home>>R&D>>Research Direction
 
 

Jinhe is devoted to R&D on extraction, synthesization,seperation, and purification of anticancer drum raw materials and the intermediates. Currently Jinhe is mainly directed at:

     ●The extraction optimization and purification process of botanical APIs and intermediates.

     ●The synthesization route of botanical Anti-cancer drug such as
        Paclitaxel, docetaxel, Irinotecan HCl trihydrate and Etoposide etc.

     ●The synthesization route of Paclitaxel and its
        optimization research.

     ●The synthesis process of other Anti-cancer API.

 

 

 
 
 
CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
Ǯ